Lower Efficacy Rate Of J&J’s COVID-19 Vaccine Presents ‘Messaging Challenge’

 
• By Brenda Sandburg
  
Janssen vaccine and name (shutterstock)
J&J's COVID-19 vaccine demonstrates 66% overall effectivess, 100% protection against hospitalization and death • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet